Freebird Partners LP 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 5:31 pm Purchase |
2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 5,136,696 9.990% |
4,083,209 (+387.59%) |
Filing |
| 2023-07-20 7:52 pm Purchase |
2023-07-14 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 1,053,487 19.990% |
355,976 (+51.04%) |
Filing |
| 2023-04-04 5:14 pm Purchase |
2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 697,511 12.600% |
424,928 (+155.89%) |
Filing |
| 2022-12-02 5:01 pm Purchase |
2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 272,583 5.300% |
272,583 (New Position) |
Filing |